This specialized biomarker panel is designed to aid in the evaluation of Chronic Inflammatory Response Syndrome (CiRS) and related chronic inflammatory conditions. It includes plasma-based ELISA tests for TGF-beta 1, VEGF, C4a, Amsh, and C3a Fragment, along with serum-based assays for MMP-9 and Leptin. These markers provide insights into immune dysregulation, vascular function, and metabolic signaling, supporting both diagnostic clarity and therapeutic planning.

Biomarkers